(-0.13%) 5 205.75 points
(-0.09%) 39 159 points
(-0.21%) 18 148 points
(0.54%) $79.42
(0.09%) $2.19
(0.16%) $2 325.90
(0.94%) $27.86
(0.74%) $991.90
(0.07%) $0.931
(0.13%) $10.91
(0.05%) $0.801
(0.28%) $92.00
Live Chart Being Loaded With Signals
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada...
Stats | |
---|---|
今日成交量 | 1 617.00 |
平均成交量 | 17 011.00 |
市值 | 36.49M |
EPS | $0 ( 2024-04-03 ) |
下一个收益日期 | ( $0 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.800 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Warma Neil K | Buy | 200 000 | Option (right to buy) |
2023-12-04 | Sclar Jeremy M. | Buy | 150 000 | Series 2 Preferred Shares, no par value |
2022-10-11 | Sclar Jeremy M. | Buy | 26 217 | Warrants to Purchase Common Shares, no par value |
2023-12-04 | Sclar Jeremy M. | Sell | 150 000 | Series 1 Preferred Shares, no par value |
2023-12-25 | Title 19 Promis | Sell | 0 | Common Shares, no par value |
INSIDER POWER |
---|
-43.18 |
Last 83 transactions |
Buy: 847 135 | Sell: 2 093 488 |
ProMIS Neurosciences, 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
ProMIS Neurosciences, 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-1.070 |
FY | 2023 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-1.070 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-1.700 |
Financial Reports:
No articles found.
ProMIS Neurosciences,
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。